Published in Cancer Gene Therapy Week, August 9th, 2010
"Strikingly, the p73 binding profile is indistinguishable from the previously described binding profile for p63 in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Gene Therapy Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.